Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
Women With Aggressive HER2 Positive Breast Cancer May Miss Out On Chemotherapy And Trastuzumab (Herceptin®)
http://www.medicalnewstoday.com/articles/126019.php
Women with a particularly aggressive form of early stage (primary) breast cancer may miss out on optimal treatment which may include chemotherapy and trastuzumab (Herceptin) as a result of untimely or missing HER2-status test results, according to doctors responding to the results from a North of England Cancer Network audit of HER2-testing today.
Inconclusive Genetic Testing Results Might Lead To Anxiety About Breast Cancer, Study Says
http://www.medicalnewstoday.com/articles/125958.php
<BR />Although genetic testing can provide some women with information about their risk for breast cancer, women who receive inconclusive results from genetic testing might be left with persistent anxiety, according to a study published recently in the journal <A href="http://boardroom.
Baltimore Sun Publishes Series On Breast Cancer Vaccine Trial
http://www.medicalnewstoday.com/articles/125957.php
<BR />The Baltimore<CITE> Sun</CITE> recently published a six-part <A href="http://www.baltimoresun.com/news/health/bal-vaccine,0,2108606.storygallery" target=_new>series</A> that examines the lives of four women living with terminal breast cancer who enrolled in an experimental vaccine trial run by Leisha Emens, an oncologist at <A href="http://www.
----------------------------------------------
** CANCER / ONCOLOGY News **
Genentech Announces Phase III Study Of Avastin Plus Chemotherapy In Adjuvant Colon Cancer Will Continue
http://www.medicalnewstoday.com/articles/126042.php
Genentech, Inc. (NYSE:DNA) today announced that it has been informed by the National Surgical Adjuvant Breast and Bowel Project (NSABP) that an ongoing Phase III study (NSABP C-08) of Avastin® (bevacizumab) plus chemotherapy in patients with early-stage colon cancer will continue as planned.
Discovery Of A Gene Critical For Development Of Lymphatic System, Implications For Cancer And Lymphatic Disorders Treatment
http://www.medicalnewstoday.com/articles/126031.php
Researchers have identified a gene critical for the development of the lymphatic system in a discovery that will have implications for treatment of cancer and lymphatic disorders and other diseases.
Cancer Research - Applications Invited For 2009 Landon Foundation-AACR INNOVATOR Awards
http://www.medicalnewstoday.com/articles/126023.php
The American Association for Cancer Research, in partnership with the Kirk A. and Dorothy P. Landon Foundation, is accepting applications for grants supporting innovation in cancer prevention research and international collaboration.
Women With Aggressive HER2 Positive Breast Cancer May Miss Out On Chemotherapy And Trastuzumab (Herceptin®)
http://www.medicalnewstoday.com/articles/126019.php
Women with a particularly aggressive form of early stage (primary) breast cancer may miss out on optimal treatment which may include chemotherapy and trastuzumab (Herceptin) as a result of untimely or missing HER2-status test results, according to doctors responding to the results from a North of England Cancer Network audit of HER2-testing today.
Provectus Pharmaceuticals Adds Fourth Center To Phase 2 Clinical Trial Of PV-10 For Stage III And IV Metastatic Melanoma Treatment
http://www.medicalnewstoday.com/articles/126010.php
Provectus Pharmaceuticals, Inc. (OTCBB: PVCT) has begun recruitment for its Phase 2 clinical trial of the Company's lead oncology agent PV-10 at a fourth major center, now covering Adelaide, Australia in addition to Sydney and Brisbane, Australia, as well as M.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
Australia's 2008 Prime Minister's Prize For Science Awarded To Ian Frazer
http://www.medicalnewstoday.com/articles/125982.php
UQ's cervical cancer vaccine co-creator Professor Ian Frazer has won the 2008 Prime Minister's Prize for Science.Professor Frazer, Director of UQ's Diamantina Institute for Cancer, Immunology and Metabolic Medicine, was presented with his prize by Prime Minister Kevin Rudd at a special ceremony in the Great Hall, Parliament House Canberra on October 16.
----------------------------------------------
** COLORECTAL CANCER News **
Genentech Announces Phase III Study Of Avastin Plus Chemotherapy In Adjuvant Colon Cancer Will Continue
http://www.medicalnewstoday.com/articles/126042.php
Genentech, Inc. (NYSE:DNA) today announced that it has been informed by the National Surgical Adjuvant Breast and Bowel Project (NSABP) that an ongoing Phase III study (NSABP C-08) of Avastin® (bevacizumab) plus chemotherapy in patients with early-stage colon cancer will continue as planned.
----------------------------------------------
** LUNG CANCER News **
No news for this category today.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
Discovery Of A Gene Critical For Development Of Lymphatic System, Implications For Cancer And Lymphatic Disorders Treatment
http://www.medicalnewstoday.com/articles/126031.php
Researchers have identified a gene critical for the development of the lymphatic system in a discovery that will have implications for treatment of cancer and lymphatic disorders and other diseases.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
Many Options Now For Managing Prostate Symptoms, But New Surgical Techniques Are Often Over-promoted
http://www.medicalnewstoday.com/articles/126022.php
In the last few years, the treatment options for prostate problems have expanded. The German Institute for Quality and Efficiency in Health Care (IQWiG) has assessed new treatments and warns that some new surgical techniques are being heavily promoted without first having been adequately evaluated.
The Choice Of Treatment For Enlarged Prostates Needs Careful Consideration
http://www.medicalnewstoday.com/articles/125995.php
In the last few years, the treatment options for prostate problems have expanded. The German Institute for Quality and Efficiency in Health Care (IQWiG) has assessed new treatments and warns that some new surgical techniques are being heavily promoted without first having been adequately evaluated.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment